☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Innovent
HUTCHMED and Innovent Report the NMPA’s Conditional Approval of Elunate Plus Tyvyt to Treat Advanced Endometrial Cancer
December 3, 2024
PharmaShots Weekly Snapshots (July 29 – August 02, 2024)
August 2, 2024
PharmaShots Weekly Snapshots (June 10 – June 14, 2024)
June 14, 2024
PharmaShots Weekly Snapshots (May 27 – May 31, 2024)
May 31, 2024
PharmaShots Weekly Snapshots (May 20 – May 24, 2024)
May 24, 2024
PharmaShots Weekly Snapshots (May 06 – May 10, 2024)
May 10, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.